Comprehensive Study Notes on Shigella Infections and Pathogenesis and Characteristics of Shigella Infections

Overview of Shigella Infections

  • Disease: Bacilliary Dysentry (also known as Shigellosie).

  • Causative Agents:

    • Shigella dysenterice

    • Shigella Flexresi

    • Shigella sorrei

  • Pathogen Type: An aerobic intracellular pathogen.

  • Disease Characteristics:

    • Classified as an intestinal disease.

    • Occupies the GI tract.

    • Is actively invasive, similar to Ontmorilla, though activities occur at different times.

Transmission and Infectious Dose

  • Transmission Pathways:

    • Person to person.

    • Unime to person.

    • Food.

    • Mainly from the fecal-oral route described by the 4Fs: fingers, feces, food, and flies.

  • Infectious Dose: 1020010 - 200 organisms.

Clinical Progression and Symptoms

  • Incubation time: 131 - 3 days.

  • Duration: 474 - 7 days.

  • Standard Symptoms:

    • Painful bowel movements and cramps.

    • Nausea and vomiting.

    • Loss of appetite.

    • Diarrheal discharge, which is often bloody.

    • High fever.

  • Symptoms in highly infected individuals: Kidney fever.

  • Pediatric Complications: Seizures can occur in children under 22 years of age, which can be fatal.

Epidemiology and Treatment

  • Annual Global Burden: Approximately 160160 million cases every year.

  • Mortality Rate: 600,000600,000 to 11 million deaths annually.

  • Demographic Impact: Deaths occur mostly among young kids in developing areas of the world.

  • Current Treatment Challenges:

    • Resistance to many antibiotics has emerged, leading to a lack of effective treatments in many cases.

    • No vaccine is currently available.

Genomic and Structural Features

  • Genomic Comparisons: Shigella has features common to Pathogenic E.coli (genomically very similar), Salmonella, and Listeria.

  • Motility Features:

    • Shigella possesses no flagella.

    • The bacteria are non-mobile outside of cells (extracellular).

    • The bacteria are mobile inside cells.

  • Molecular Mechanisms: Controls the host cell cytoskeleton, a trait shared with C.coli, Listeria, and Ontmorilla.

Invasion Mechanisms and Type 3 Secretion System (T3SS)

  • Effector Injection: Uses a type 3 secretion system to inject effector PTs (proteins) into the host cell.

  • Cellular Entry:

    • Causes active invasion.

    • Causes massive amounts of membrane ruffling to invade host cells.

    • Gains entry by controlling the actin dynamics of the cell.

  • Gap Junction Manipulation:

    • During invasion, the bacteria use T3SS effectors to control gap junctions.

    • Specifically hijacks Connexin 26 gap junction hemichannels.

    • This hijacking causes the release of ATP from host cells into the surrounding media.

    • The release of ATP further increases bacterial invasion.

Intracellular Lifecycle and Motility

  • Phases of Intracellular Colonization:

    • Enters the cells and is initially found in a vacuole.

    • Lyses the vacuole to enter the cytoplasm.

    • Replicates in the host cell cytoplasm.

  • Actin Recruitment and Propelling:

    • Generates an effector called IcsA (comparable to ActA in Listeria).

    • IcsA is embedded in 11 pole of the Shigella bacterium.

    • IcsA recruits actin filaments (F-actin and N-WASP/NCA-P) to propel the bacteria around the cell.

    • This is known as Shigella motility in infected cells; Shigella flexneri specifically uses IcsA for this purpose.

Shiga Toxin

  • Origin: The Shiga toxin was initially described in Shigella, not E.coli.

  • Functional Mechanism: The A subunit of the toxin can bind to host ribosomes, inhibiting PT synthesis.

  • Pathological Effects:

    • Can generate diarrhea independently.

    • Causes watery diarrhea containing blood, mucus, and pus.

Study Models and Experimental Challenges

  • Animal Models for Shigella:

    • Monkey: Expensive and ethically challenging, but gives a disease similar to humans.

    • Mice: Not susceptible to the infections; the reason for this is unknown.

    • Rabbit: Limited to the use of intestinal segments (loops) following bacterial injection.

    • Young Guinea Pigs (250G250\,G or less): Develop shigellaris.

Cell-to-Cell Spreading and Junction Targeting

  • Infection Strategy: Shigella targets the tricellular junctions of cells for efficient cell-to-cell spreading.

  • Tricellular Junctions:

    • Unique types of tight junctions (TJ).

    • Use the PT "tricellulin" to fuse adjacent membranes.

    • Paired TJ strands, tricellulin, and occludin merge at these sites.

  • Process of Cell-to-Cell Movement:

    • Shigella couples tricellulin identification with clathrin-mediated endocytosis to move between cells.

    • Step-by-step mechanism:

      1. Actin-based motility leads to protrusion formation.

      2. PI 3-kinase activation occurs.

      3. PtdIns(3,4,5)PPtdIns(3,4,5)P involvement.

      4. Clathrin-dependent endocytosis takes place.

      5. Vacuole lysis followed by resumed actin-based motility.